1- Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C. Threats to applicability of randomised trials. Exclusions and selective participation. J Health Serv Res Policy 1999; 4: 112–21.
2- Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D; Thymoglobulin Induction Study Group: Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 355: 1967–1977, 2006
3- Noël C, Abramowicz D, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squifflet JP, Bayle F, Wissing KM, Hazzan M: Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol 20: 1385–1392, 2009
4- Alloway RR, Woodle ES, Abramowicz D, Segev DL, Castan R, Ilsley JN, Jeschke K, Somerville KT, Brennan DC. Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation. Am J Transplant 19: 2252-61, 2019
5- Webster AC, Ruster LP, McGee RG, Matheson SL, Higgins GY, Willis NS, Chapman JR, Craig JC. Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database Syst Rev 2010; CD003897
6- Mourad G, Garrigue V, Squifflet JP, Besse T, Berthoux F, Alamartine E, Durand D, Rostaing L, Lang P, Baron C, Glotz D, Antoine C, Vialtel P, Romanet T, Lebranchu Y,AlNajjarA,Hiesse C, Potaux L, Merville P, Touraine JL, Lefrancois N, Kessler M, Renoult E, Pouteil-Noble C, Cahen R, Legendre C,Bedrossian J, LePogampP, Rivalan J,Olmer M, Purgus R,Mignon F,Viron B, Charpentier B: Induction versus non-induction in renal transplant recipients with tacrolimus-basedimmunosuppression. Transplantation 72: 1050–1055, 2001
7- Lebranchu Y, Bridoux F, Büchler M, Le Meur Y, Etienne I, Toupance O, Hurault de Ligny B, Touchard G, Moulin B, Le Pogamp P, Reigneau O, Guignard M, Rifle G: Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receivingMMFcontaining triple therapy. Am J Transplant 2: 48–56, 2002
8- Sollinger H, KaplanB, PescovitzMD, PhilosopheB, RozaA, BraymanK, Somberg K: Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection. Transplantation 72: 1915–1919, 2001
9- Crepin T, carron C, Roubiou C, Gaugler B, Gaiffe E, Simula-Faivre D, Ferrand C, Tiberghien P, Chalopin JM, Moulin B, Frimat L, Rieu P, Saas P, Ducloux D, Bamoulid J. ATG-induced immune senescence: clinical implications in renal transplant recipients. Am J Transplant 2015; 15: 1028-38
10- Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411–422
11- Joffe MM, Rosenbaum PR: Invited commentary: Propensity scores. Am J Epidemiol 150: 327–333, 1999
12- Rebellato LM, Gross U, Verbanac KM, Thomas JM. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation. 1994;57(5):685-694.
13- Bonnefoy-Berard N, Vincent C, Revillard JP. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation. 1991;51(3):669-673.
14- Ducloux D, Courivaud C, Bamoulid J, Vivet B, Chabroux A, Deschamps M, Rebibou JM, Ferrand C, Chalopin JM, Tiberghien P, Saas P. Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation. J Am Soc Nephrol. 2010;21: 868-75
15- Ducloux D, Carron PL, Rebibou JM, Aubin F, Fournier V, Bresson-Vautrin C, Blanc D, Humbert P, Chalopin JM. CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation. 1998; 65: 1270-2.
16- Luan FL, Samaniego M, Kommareddi M, Park JM, Ojo AO. Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients. Transpl Infect Dis. 2010 Dec;12(6):473-9
17- Crepin T, Gaiffe E, Courivaud C, Roubiou C, Laheurte C, Moulin B, Frimat L, Rieu P, Mousson C, Durrbach A, Heng AE, Saas P, Bamoulid J, Ducloux D. Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infections. Transpl Infect Dis. 2016; 18: 415-22